live In the news:
Stocks making the biggest moves midday: Wynn Resorts, Rocket Lab USA, Cassava Sciences and more - Cassava Sciences Adviser Indicted on Fraud Charges

Cassava Sciences

16 days ago
bookmarkSave

Key facts

Classified as: organization

Summary

Cassava Sciences is a company. It is located in Austin, the United States. The company is part of the Health Care sector, specifically in the Biotechnology industry.

Business

  • Assets: 266.8M $
  • Debt: 213K $
  • Employees: 24 people
  • Free cash flow: -56070500 $
  • Market cap: 1.3B $
  • Revenues: get premium Premium to see estimate

Stocks from Cassava Sciences

Explore more on business

Talking Points:

  • Cassava Sciences, Inc.
  • The Investor Relations website contains information about Cassava Sciences, Inc.'s business for stockholders, potential investors, and financial analysts.
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
Learn more about talking points

In literature

There is no book written about Cassava Sciences in the database

Related

Connected or similar:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter

This content can be used under the CC BY 4.0 license